# A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

> **NCT07338786** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Changchun BCHT Biotechnology Co.** · enrollment: 80 (estimated)

## Conditions studied

- RabiesPrevention

## Interventions

- **DRUG:** Lyophilized Human Rabies Vaccine (Human Diploid Cell)

## Key facts

- **NCT ID:** NCT07338786
- **Lead sponsor:** Changchun BCHT Biotechnology Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-13
- **Primary completion:** 2026-01-04
- **Final completion:** 2026-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338786, "A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07338786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*